Read the latest news from regional and global sources, presenting different voices and perspectives.
Antony heading to Real Betis for medical, Solanke blow for Spurs: football news – live
The Guardian
·
January 24, 2025
Key eventsShow key events onlyPlease turn on JavaScript to use this feature John Duerden has written about Ange Postecoglou’s importance to the entire Asian football landscape: It is not just Australian fans hoping that Ange Postecoglou can turn...
Astellas Pharma’s Vyloy receives China NMPA approval for first-line treatment of advanced gastric or GEJ adenocarcinoma
Pharmabiz.com
·
Astellas Pharma Inc. announced that China’s National Medical Products Administration (NMPA) has approved Vyloy (zolbetuximab), in combination with fluoropyrimidine- and platinum-containing chemotherapy, for the first-line treatment of patients...
Same-sex couples can now marry in tiny nation of Liechtenstein
QNews
·
January 5, 2025
Fancy an Alpine wedding? Same-sex couples can now officially get married in Liechtenstein as the tiny but picturesque European country’s marriage equality laws begin. Last May, Liechtenstein’s parliament voted to legalise same-sex marriage, making...
China's National Medical Products Administration (NMPA) Approves VYLOYTM (Zolbetuximab) For First-Line Treatment Of Advanced Gastric Or Gastroesophageal Junction Adenocarcinoma
MENAFN
·
January 5, 2025
(MENAFN- PR Newswire) - China has the highest number of cases and deaths from gastric cancer of any country worldwide1 - - Zolbetuximab is the first and only therapy approved in China to target claudin 18.2, a biomarker expressed by 35% of Chinese...
Biomanufacturing: Scale-up vs Scale-out Economics
BioPharma Dive
·
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing the on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...
4 major trends shaping today’s oncology market
BioPharma Dive
·
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing this on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...
Dynex Partners With Incor To Transform Healthcare AI With Quantum-As-A-Service Technology
MENAFN
·
December 20, 2024
(MENAFN- GlobeNewsWire - Nasdaq) Vaduz, Liechtenstein, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Dynex , a leader in Quantum-as-a-Service (QaaS) technology, has welcomed the Heart Institute (InCor) at the University of São Paulo Medical School as a...
The interplay of membrane tension and FtsZ filament condensation on the initiation and progression of cell division in B. subtilis
eLife
·
The ability of cells to divide into two is an essential process for all organisms, and accordingly, every cell examined so far encodes a machinery to facilitate its division. At the physical level, any cell division apparatus must first exert...
Bojan Miovski on his Rangers aims, the Aberdeen backlash and that Celtic penalty call
The Herald (Scotland)
·
September 1, 2025
Miovski worked hard from kick-off, had an appeal for an early penalty waved away by referee Don Robertson and probed the visitors’ defence tirelessly for an opening until being replaced by Cyriel Dessers midway through the second half. However,...
Implantica Announces Two New Refluxstoptm University Hospitals In Spain, Leading To 10 Active Centers And Many More To Join Soon
MENAFN
·
December 18, 2024
(MENAFN- PR Newswire) VADUZ, Liechtenstein, Dec. 18, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStopTM for the treatment of...
After temporary reprieve, Advanz Pharma's liver med Ocaliva loses marketing nod in Europe
Fierce Pharma
·
December 2, 2024
After a rough few months for Intercept and Advanz Pharma's Ocaliva on both sides of the Atlantic, the other shoe has dropped for the rare liver disease drug in Europe. The General Court of the European Union last week decided not to extend a...
Formosa Pharmaceuticals and Medvisis Switzerland Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain
WFMZ - Pennsylvania
·
TAIPEI, Nov. 28, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Medvisis Switzerland AG ("Medvisis") in Switzerland and...
Advanz Pharma’s liver disease drug pulled from European market after court hearing
Pharmaceutical Technology
·
November 28, 2024
Advanz Pharma’s liver disease drug Ocaliva (obeticholic acid) will no longer be available in Europe after the General Court of the European Union upheld a decision by the European Commission (EC) to revoke its conditional marketing authorisation...
Purpose-related investments: Liechtenstein opens up another dimension of philanthropy
The European Magazine
·
November 26, 2024
In July 2024, Liechtenstein further optimised its framework conditions to enable charitable foundations to make purpose-related investments in the form of impact investing and venture philanthropy. It is important to stress that tax exemption, an...
China bans imports of ruminant animals from Liechtenstein due to bluetongue disease
KFGO - North Dakota
·
November 12, 2024
BEIJING (Reuters) -China has banned the direct and indirect import of ruminants and related products from Liechtenstein due to an outbreak of bluetongue disease, the General Administration of Customs said on its website on Tuesday. The move...
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
The AI Journal
·
August 26, 2025
– Yeytuo® is the First and Only European Commission (EC)-Authorized HIV PrEP Option Offering 6 Months of Protection – – Accelerated EC Decision Comes After U.S. FDA Approval in June – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc....
LEO Pharma's Anzupgo cream to treat chronic hand eczema receives marketing approval in Switzerland
Pharmabiz.com
·
LEO Pharma A/S, a global leader in medical dermatology, announced that Swissmedic, Switzerland’s national regulatory agency for approving and overseeing therapeutic products, has granted marketing approval for Anzupgo (delgocitinib) cream. The...
The Minister of Health Inaugurates a Hospital in Angola Where 20 Cuban Doctors Work
14ymedio
·
November 17, 2024
The inauguration of the Comandante Raúl Díaz Argüelles general hospital in the Angolan province of Cuanza Sur / Prensa Latina 14ymedio, Havana, October 21, 2024 — The Minister of Public Health of Cuba, José Ángel Portal Miranda, inaugurated the...
Implantica Submits FDA PMA Application Clinical Module 2 For Refluxstoptm For U.S. Market Approval
MENAFN
·
November 14, 2024
(MENAFN- PR Newswire) VADUZ, Liechtenstein, Nov. 14, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStopTM for the treatment of...
Orphan designation: Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene Treatment of X-linked chronic granulomatous disease, 09/02/2012 Positive
European Medicines Agency
·
November 10, 2024
At the time of designation, X-linked CGD affected less than 0.02 in 10,000 people in the European Union (EU)*. This is equivalent to a total of fewer than 1,000 people, and is below the ceiling for orphan designation, which is 5 people in 10,000....